Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk.
BACKGROUND: Somatic mutations in phosphoinositide-3-kinase catalytic subunit alpha (PIK3CA) are frequent in breast tumours and have been associated with oestrogen receptor (ER) expression, human epidermal growth factor receptor-2 overexpression, lymph node metastasis and poor survival. The goal of...
| Հիմնական հեղինակներ: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Ձևաչափ: | Journal article |
| Լեզու: | English |
| Հրապարակվել է: |
2011
|
| _version_ | 1826257490182930432 |
|---|---|
| author | Stevens, K Garcia-Closas, M Fredericksen, Z Kosel, M Pankratz, V Hopper, J Dite, G Apicella, C Southey, M Schmidt, M Broeks, A Van 't Veer, L Tollenaar, R Fasching, P Beckmann, M Hein, A Ekici, AB Johnson, N Peto, J dos Santos Silva, I Gibson, L Sawyer, E Tomlinson, I Kerin, M Chanock, S |
| author_facet | Stevens, K Garcia-Closas, M Fredericksen, Z Kosel, M Pankratz, V Hopper, J Dite, G Apicella, C Southey, M Schmidt, M Broeks, A Van 't Veer, L Tollenaar, R Fasching, P Beckmann, M Hein, A Ekici, AB Johnson, N Peto, J dos Santos Silva, I Gibson, L Sawyer, E Tomlinson, I Kerin, M Chanock, S |
| author_sort | Stevens, K |
| collection | OXFORD |
| description | BACKGROUND: Somatic mutations in phosphoinositide-3-kinase catalytic subunit alpha (PIK3CA) are frequent in breast tumours and have been associated with oestrogen receptor (ER) expression, human epidermal growth factor receptor-2 overexpression, lymph node metastasis and poor survival. The goal of this study was to evaluate the association between inherited variation in this oncogene and risk of breast cancer. METHODS: A single-nucleotide polymorphism from the PIK3CA locus that was associated with breast cancer in a study of Caucasian breast cancer cases and controls from the Mayo Clinic (MCBCS) was genotyped in 5436 cases and 5280 controls from the Cancer Genetic Markers of Susceptibility (CGEMS) study and in 30 949 cases and 29 788 controls from the Breast Cancer Association Consortium (BCAC). RESULTS: Rs1607237 was significantly associated with a decreased risk of breast cancer in MCBCS, CGEMS and all studies of white Europeans combined (odds ratio (OR)=0.97, 95% confidence interval (CI) 0.95-0.99, P=4.6 × 10(-3)), but did not reach significance in the BCAC replication study alone (OR=0.98, 95% CI 0.96-1.01, P=0.139). CONCLUSION: Common germline variation in PIK3CA does not have a strong influence on the risk of breast cancer. |
| first_indexed | 2024-03-06T18:19:02Z |
| format | Journal article |
| id | oxford-uuid:05a2d0fe-a0ce-42f6-904e-1f8cfa24c893 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T18:19:02Z |
| publishDate | 2011 |
| record_format | dspace |
| spelling | oxford-uuid:05a2d0fe-a0ce-42f6-904e-1f8cfa24c8932022-03-26T08:58:16ZEvaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:05a2d0fe-a0ce-42f6-904e-1f8cfa24c893EnglishSymplectic Elements at Oxford2011Stevens, KGarcia-Closas, MFredericksen, ZKosel, MPankratz, VHopper, JDite, GApicella, CSouthey, MSchmidt, MBroeks, AVan 't Veer, LTollenaar, RFasching, PBeckmann, MHein, AEkici, ABJohnson, NPeto, Jdos Santos Silva, IGibson, LSawyer, ETomlinson, IKerin, MChanock, S BACKGROUND: Somatic mutations in phosphoinositide-3-kinase catalytic subunit alpha (PIK3CA) are frequent in breast tumours and have been associated with oestrogen receptor (ER) expression, human epidermal growth factor receptor-2 overexpression, lymph node metastasis and poor survival. The goal of this study was to evaluate the association between inherited variation in this oncogene and risk of breast cancer. METHODS: A single-nucleotide polymorphism from the PIK3CA locus that was associated with breast cancer in a study of Caucasian breast cancer cases and controls from the Mayo Clinic (MCBCS) was genotyped in 5436 cases and 5280 controls from the Cancer Genetic Markers of Susceptibility (CGEMS) study and in 30 949 cases and 29 788 controls from the Breast Cancer Association Consortium (BCAC). RESULTS: Rs1607237 was significantly associated with a decreased risk of breast cancer in MCBCS, CGEMS and all studies of white Europeans combined (odds ratio (OR)=0.97, 95% confidence interval (CI) 0.95-0.99, P=4.6 × 10(-3)), but did not reach significance in the BCAC replication study alone (OR=0.98, 95% CI 0.96-1.01, P=0.139). CONCLUSION: Common germline variation in PIK3CA does not have a strong influence on the risk of breast cancer. |
| spellingShingle | Stevens, K Garcia-Closas, M Fredericksen, Z Kosel, M Pankratz, V Hopper, J Dite, G Apicella, C Southey, M Schmidt, M Broeks, A Van 't Veer, L Tollenaar, R Fasching, P Beckmann, M Hein, A Ekici, AB Johnson, N Peto, J dos Santos Silva, I Gibson, L Sawyer, E Tomlinson, I Kerin, M Chanock, S Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk. |
| title | Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk. |
| title_full | Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk. |
| title_fullStr | Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk. |
| title_full_unstemmed | Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk. |
| title_short | Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk. |
| title_sort | evaluation of variation in the phosphoinositide 3 kinase catalytic subunit alpha oncogene and breast cancer risk |
| work_keys_str_mv | AT stevensk evaluationofvariationinthephosphoinositide3kinasecatalyticsubunitalphaoncogeneandbreastcancerrisk AT garciaclosasm evaluationofvariationinthephosphoinositide3kinasecatalyticsubunitalphaoncogeneandbreastcancerrisk AT fredericksenz evaluationofvariationinthephosphoinositide3kinasecatalyticsubunitalphaoncogeneandbreastcancerrisk AT koselm evaluationofvariationinthephosphoinositide3kinasecatalyticsubunitalphaoncogeneandbreastcancerrisk AT pankratzv evaluationofvariationinthephosphoinositide3kinasecatalyticsubunitalphaoncogeneandbreastcancerrisk AT hopperj evaluationofvariationinthephosphoinositide3kinasecatalyticsubunitalphaoncogeneandbreastcancerrisk AT diteg evaluationofvariationinthephosphoinositide3kinasecatalyticsubunitalphaoncogeneandbreastcancerrisk AT apicellac evaluationofvariationinthephosphoinositide3kinasecatalyticsubunitalphaoncogeneandbreastcancerrisk AT southeym evaluationofvariationinthephosphoinositide3kinasecatalyticsubunitalphaoncogeneandbreastcancerrisk AT schmidtm evaluationofvariationinthephosphoinositide3kinasecatalyticsubunitalphaoncogeneandbreastcancerrisk AT broeksa evaluationofvariationinthephosphoinositide3kinasecatalyticsubunitalphaoncogeneandbreastcancerrisk AT vantveerl evaluationofvariationinthephosphoinositide3kinasecatalyticsubunitalphaoncogeneandbreastcancerrisk AT tollenaarr evaluationofvariationinthephosphoinositide3kinasecatalyticsubunitalphaoncogeneandbreastcancerrisk AT faschingp evaluationofvariationinthephosphoinositide3kinasecatalyticsubunitalphaoncogeneandbreastcancerrisk AT beckmannm evaluationofvariationinthephosphoinositide3kinasecatalyticsubunitalphaoncogeneandbreastcancerrisk AT heina evaluationofvariationinthephosphoinositide3kinasecatalyticsubunitalphaoncogeneandbreastcancerrisk AT ekiciab evaluationofvariationinthephosphoinositide3kinasecatalyticsubunitalphaoncogeneandbreastcancerrisk AT johnsonn evaluationofvariationinthephosphoinositide3kinasecatalyticsubunitalphaoncogeneandbreastcancerrisk AT petoj evaluationofvariationinthephosphoinositide3kinasecatalyticsubunitalphaoncogeneandbreastcancerrisk AT dossantossilvai evaluationofvariationinthephosphoinositide3kinasecatalyticsubunitalphaoncogeneandbreastcancerrisk AT gibsonl evaluationofvariationinthephosphoinositide3kinasecatalyticsubunitalphaoncogeneandbreastcancerrisk AT sawyere evaluationofvariationinthephosphoinositide3kinasecatalyticsubunitalphaoncogeneandbreastcancerrisk AT tomlinsoni evaluationofvariationinthephosphoinositide3kinasecatalyticsubunitalphaoncogeneandbreastcancerrisk AT kerinm evaluationofvariationinthephosphoinositide3kinasecatalyticsubunitalphaoncogeneandbreastcancerrisk AT chanocks evaluationofvariationinthephosphoinositide3kinasecatalyticsubunitalphaoncogeneandbreastcancerrisk |